Ignite Creation Date:
2025-12-25 @ 12:21 AM
Ignite Modification Date:
2026-01-04 @ 8:51 AM
Study NCT ID:
NCT05921058
Status:
COMPLETED
Last Update Posted:
2023-06-27
First Post:
2023-03-09
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
The Effects of Mesenchymal Stem Cell Secretome in Lupus Patients
Sponsor:
Universitas Sebelas Maret
Organization:
Study Overview
Official Title:
The Effects of Mesenchymal Stem Cell Secretome in Lupus Patients
Status:
COMPLETED
Status Verified Date:
2023-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This research is a clinical trial of administering mesenchymal stem cell secretome to lupus patients.
Detailed Description:
This research is experimental. The study was conducted on 30 SLE patient subjects. the treatment group who got the mesenchymal stem cell secretome on the 1st, 2nd day, 3rd, 4th, 5th, 6th, 7th, 14th, 21st, and 28th days. ESR, hs-CRP, C3, C4, interlukin 6, anti-ds-DNA antibody, MEX SLEDAI score, and assessment of drug side effects before and after therapy were collected. Statistical test with paired difference test with p \< 0.05
Study Oversight
Has Oversight DMC:
True
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: